Lindsey Murphy, M.D., M.S.

800-826-4673
Lindsey Murphy, M.D., M.S.
Pediatric Hematologist-Oncologist
Clinical Expertise
  • Pediatric Hematology - Oncology
Academic Appointments
  • Assistant Professor, Department of Pediatrics
Clinical Teams
Pediatric Hematology-Oncology
Pediatric Leukemia and Lymphoma

Pediatric oncologist Lindsey Murphy, M.D., M.S., looks at the patients and families she serves as teammates. She prioritizes open, honest communication with them and makes sure she gets to know them to ensure that each treatment plan is aligned with that family’s goals. She’s excited about the rapid progress in her field and the chance to offer patients new treatments that give results.

Dr. Murphy is a physician-scientist with multiple lines of investigation aiming to advance leukemia treatment. She developed a test to help assess the success of CAR T cell therapy, an innovative treatment that augments a patient’s own immune cells in order to fight cancer. She has also designed several clinical trials testing CAR T cell therapy for B cell acute lymphoblastic leukemia. Other investigations focus on improving the process of treatment itself in stem cell transplantation, chemotherapy and oncology inpatient care.

Raised in Southern California, Dr. Murphy enjoys quality time with family and close friends, cooking and baking when away from work. She is a fan of all things Disney.
 

Location

Education & Experience

Board Certifications
  • 2023, Board Eligible, Pediatric Hematology/Oncology
  • 2019, Board Certification, General Pediatrics, American Board of Pediatrics
Degrees
  • 2022, Master of Science, Clinical Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado
  • 2016, Doctor of Medicine, University of Nevada School of Medicine, Reno, Nevada
Fellowship
  • 2022, Pediatric Hematology/Oncology, University of Colorado Anschutz Medical Campus/Children’s Hospital Colorado, Aurora, Colorado
Residency
  • 2019, Pediatrics, University of Washington/Seattle Children’s Hospital, Seattle, Washington
Professional Experience
  • 2023-present, Assistant Professor, Department of Pediatrics, City of Hope, Duarte, California

Awards & Memberships

Awards

  • 2022, Swim Across America Fellowship Grant Award Recipient
  • 2020, T32 Cancer Immunology and Experimental Therapeutics Grant Award Recipient
  • 2015, Alpha Omega Alpha, National Medical Honor Society, Junior AOA Honoree
  • 2015, Medical Student Rising Star Award, Clark County Medical Society
  • 2015, Caroline Graham-Lamberts Memorial Scholarship
  • 2014, Soroptimist International of Truckee Meadows, Jack Simon Graduate Scholarship
  • 2013-2015, Pennington Medical Scholarship
  • 2013, Outstanding First Year Medical Student, UNSOM
  • 2010-2011, Postgraduate Fulbright Scholar Fellowship Award
  • 2010, Most Outstanding Biology Graduate, Pepperdine University
  • 2009, National Science Foundation – Research Experience for Undergraduate Fellowship Award

Memberships

  • American Society of Hematology
  • American Society of Pediatric Hematology/Oncology
  • Children’s Oncology Group
  • American Society of Clinical Oncology
  • American Association of Cancer Research
  • American Academy of Pediatrics
  • Alpha Omega Alpha, National Medical Honor Society
  • American Medical Women’s Association
  • American Medical Association

Publications

  • Murphy L, Aldoss I. More opportunities to advance paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia. Lancet Haematol. 2023 Jul;10(7):e479-e481.

  • Murphy L, Marians R, Miller K, Brenton M, Mallo R, Kohler ME, Fry T, Winters A. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products. Cytotherapy. 2023 Jan;25(1):94-102.

  • Murphy L, Miller K, Winters A, Franklin A, Verneris M, Keating A. Time to transplantation and pediatric acute myeloid leukemia outcomes. Bone Marrow Transplant. 2023 Mar;58(3):343-345.

  • Murphy L, Maloney K, Gore L, Blanchette E. Hypertension in pediatric leukemia patients: prevalence, impact, and management strategies. Integrated Blood Pressure Control. 2022 Jan 19;15:1-10.
  • Murphy L, Ramirez E, Trinh V, Herman A, Anderson V, Brewster J. Endoplasmic reticulum stress or mutation of an EF-hand Ca2+-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis. Cell Stress Chaperones. 2011;16(6):607–619.